Medicinal Cannabis Legislation Amendment (Securing Patient Access) Bill 2017
Progress
| Date | Step |
|---|---|
| Senate | |
| 12 Sep 2017 | Introduced and read a first time |
| 12 Sep 2017 | Second reading moved |
| 19 Oct 2017 | Second reading debate |
| 19 Oct 2017 | Second reading agreed to |
| 19 Oct 2017 | Third reading agreed to |
| House | |
| 19 Oct 2017 | Introduced and read a first time |
| 19 Jun 2018 | Removed from the Notice Paper in accordance with (SO 42) |
Amends:
Customs Act 1901
- provide that prohibited goods intended to be used as medicinal cannabis products are, for the purpose of satisfying import conditions, taken to be drugs required for medical purposes
- provide that goods permitted to be supplied for the purposes stated in the Therapeutic Goods Act 1989 for the Special Access Scheme Category-B, relating to clinical trials and authorised prescribers, will also be permitted to be supplied for the Special Access Scheme Category-A, relating to seriously ill patients with a condition from which death is reasonably likely to occur within a matter of months
Narcotic Drugs Act 1967
- allow the secretary to grant a licence to manufacture medicinal cannabis if satisfied it is to be supplied to a seriously ill person in accordance with certain regulatory and notification requirements
Summary from the official bill homepage.
Documents
Official record: bill homepage at aph.gov.au, full text and documents on ParlInfo.